Showing 912 articles by Gus Cairns

Filters Content type: News, About HIV Author: Gus Cairns

Gus joined the editorial team in 2009 and has previously edited HIV Treatment Update and Preventing HIV. He currently focuses on the PrEP in Europe Initiative and on news reporting.

The search for an HIV prevention vaccine

Where next for HIV vaccines and antibody therapies?

News
11 February 2021
PrEP programmes & uptake

African studies explore reasons to start, stick with or stop PrEP

News
8 February 2021
Injectable & long-acting PrEP

Once-a-month PrEP pill easily passes its first big test

News
27 January 2021
Antibody-based prevention

Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’

News
27 January 2021
PrEP policies & guidelines

European PrEP programmes face two big issues: how to get more people coming forward, and how to serve them if they do

News
27 January 2021
PrEP programmes & uptake

Bacterial STI rates rose in the year before starting PrEP, but not during PrEP, Australian study finds

News
20 January 2021
People & personal stories

Anthony Fauci: “I don’t do this because I’m a hero. I do it because it’s necessary.”

News
14 January 2021
PrEP policies & guidelines

Is reducing anxiety a legitimate indication for PrEP in itself?

News
7 January 2021
Undetectable viral load & treatment as prevention

Undetectable viral load and transmission – information for HIV-negative people

About HIV
November 2020
Injectable & long-acting PrEP

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

News
13 November 2020
Hepatitis & HIV

European HIV doctors conduct their first-ever region-wide audit of services

News
11 November 2020
Quality of life

Living with HIV is still a burden, Dutch gay and bisexual men tell researchers

News
3 November 2020
Injectable & long-acting HIV treatment

New once-a-week drug could be part of weekly oral treatment

News
13 October 2020
Access to healthcare

European AIDS Treatment Group documents the impact of COVID on HIV services throughout Europe

News
12 October 2020
Injectable & long-acting HIV treatment

Injectable HIV therapy should save money if adherence is better than to oral therapies

News
7 October 2020
PrEP science

Trans and cis women and men all have similar levels of PrEP drugs in blood, directly observed dosing study finds

News
7 September 2020
PrEP science

Two different cases of PrEP failure despite high adherence underline that such events are rare, but should not be ignored

News
4 September 2020
PrEP

PrEP, sex, intimacy and mental health A research briefing

About HIV
September 2020
The search for a cure

Loreen Willenberg's HIV seems to have disappeared. Is this good news for the rest of us?

News
3 September 2020
The search for a cure

Elite controllers may self-vaccinate against active HIV infection, gene study suggests

News
28 August 2020
Mental & emotional health problems

Sexual compulsivity and harmful drug use decreased in men who started PrEP in Amsterdam

News
24 August 2020
Coronavirus

Two UK studies find that HIV infection may be a risk factor for dying from COVID-19

News
13 August 2020
Resistance

“Unprecedented” case of transmission of four-class resistant HIV virus reported in France

News
11 August 2020
PrEP programmes & uptake

Chicago study suggests knowledge of PrEP is not crossing over to women

News
10 August 2020